Category Specific RSS

mnd

Strategic win for Control Bionics as new HCPCS gets approved for NeuroNode

The Centers for Medicare & Medicaid Services has approved a new Healthcare Common Procedure Coding System code for the NeuroNode,…

12 months ago

PharmAust completes dosing first cohort for MND treatment, patients respond positively

Every day, two people are diagnosed in Australia with a form of motor neurone disease (MND). MND entails a group…

3 years ago

PharmAust shrinks proprietary tablet for use in COVID-19 trials

Good things come in small packages, like PharmAust’s (ASX: PAA) newest iteration of their monepantel (MPL) tablets.  The clinical stage…

4 years ago

PharmAust receives ethics approval just in time for Big Freeze

There is nothing fun about plunging into freezing cold ice water during a cold Melbourne winter. However, each year, bold…

4 years ago

Control Bionics to grow accessibility tech for the disabled with $15m IPO

Technology company, Control Bionics Limited (Proposed ASX: CBL) are one of the latest medtech companies looking to list on the…

5 years ago